Correlation Between Virax Biolabs and Sigilon Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Sigilon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Sigilon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Sigilon Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and Sigilon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Sigilon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Sigilon Therapeutics.
Diversification Opportunities for Virax Biolabs and Sigilon Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Virax and Sigilon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Sigilon Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sigilon Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Sigilon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sigilon Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Sigilon Therapeutics go up and down completely randomly.
Pair Corralation between Virax Biolabs and Sigilon Therapeutics
If you would invest (100.00) in Sigilon Therapeutics on November 27, 2024 and sell it today you would earn a total of 100.00 from holding Sigilon Therapeutics or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Sigilon Therapeutics
Performance |
| Timeline |
| Virax Biolabs Group |
| Sigilon Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Virax Biolabs and Sigilon Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Sigilon Therapeutics
The main advantage of trading using opposite Virax Biolabs and Sigilon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Sigilon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sigilon Therapeutics will offset losses from the drop in Sigilon Therapeutics' long position.| Virax Biolabs vs. Beam Therapeutics | Virax Biolabs vs. Editas Medicine | Virax Biolabs vs. Caribou Biosciences | Virax Biolabs vs. Verve Therapeutics |
| Sigilon Therapeutics vs. Reviva Pharmaceuticals Holdings | Sigilon Therapeutics vs. ZyVersa Therapeutics | Sigilon Therapeutics vs. Unicycive Therapeutics | Sigilon Therapeutics vs. Apollomics Class A |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |